AI Summary Nexavar (sorafenib) is a multikinase inhibitor used to treat unresectable hepatocellular carcinoma, dosed as 400 mg twice daily on an empty stomach.
Medically reviewed.
Nexavar (sorafenib) is a prescription targeted therapy used to treat certain types of liver cancer, kidney cancer, and thyroid cancer. In liver cancer, it is used for adults with unresectable hepatocellular carcinoma (HCC), the most common type of primary liver cancer, when surgery or local treatments are not appropriate. It belongs to a class of medications called multikinase inhibitors, which work by blocking proteins involved in tumor growth and blood vessel formation. Treatment decisions should always be individualized and guided by a healthcare professional.
This page covers Nexavar's role in liver cancer management — how it works, who may be eligible, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on whether Nexavar fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT NEXAVAR TREATMENT
Nexavar is a prescription medicine that contains sorafenib, a type of medication known as a multikinase inhibitor. It works by blocking proteins called kinases that are involved in tumor growth and in the formation of new blood vessels that feed a tumor (angiogenesis).
Nexavar is approved to treat certain types of liver cancer, kidney cancer, and thyroid cancer. In liver cancer, it is used for adults with unresectable hepatocellular carcinoma (HCC) — meaning the cancer cannot be removed with surgery or treated with local therapies alone, and adequate liver function remains.
It is typically used as long-term systemic therapy, alongside regular monitoring by your healthcare provider, such as Liver Function Tests (LFTs) and blood pressure checks.
WHO NEXAVAR MAY BE SUITABLE FOR
Eligibility for Nexavar depends on your diagnosis, liver function, and individual health needs. Nexavar is approved for adults with unresectable or advanced hepatocellular carcinoma (HCC) whose cancer cannot be treated with surgery or local therapies alone and who require systemic treatment for liver cancer. Candidates generally need adequate liver function to tolerate targeted therapy.
Your medical history, current health status, liver condition, and other medications all factor into whether Nexavar is an appropriate option for you. Because every patient's health profile is different, there is no one-size-fits-all answer to who should take Nexavar.
Treatment decisions are individualized and should be made by a qualified healthcare professional after a full assessment of your liver condition, cancer stage, and treatment goals.
ELIGIBILITY OVERVIEW
Nexavar may be considered for adults with the following conditions or treatment goals:
Before recommending Nexavar, healthcare providers evaluate several factors to determine whether it is an appropriate option, including:
HOW NEXAVAR CAN HELP
Nexavar blocks multiple kinases involved in cancer cell growth and inhibits tumor blood vessel formation (angiogenesis). By reducing the blood supply that feeds a tumor and interrupting signals that promote cancer cell survival, it works to slow tumor growth and spread.
For patients with unresectable HCC, these effects can support treatment goals such as delaying disease progression and controlling advanced liver cancer when surgery or local therapies are not options.
Nexavar is not used on its own — providers pair it with regular monitoring, such as Liver Function Tests (LFTs), blood pressure checks, and imaging, to track tumor response and manage side effects.
LIVER CANCER BENEFITS
Nexavar blocks multiple kinases, the proteins that signal cancer cells to grow and divide. This helps slow the growth of hepatocellular carcinoma (HCC). It is taken as a tablet and works throughout the body, not only at one tumor site.
A growing tumor depends on new blood vessels, a process called angiogenesis. Nexavar inhibits this process, which reduces the blood supply tumors need and helps slow tumor growth and spread.
Nexavar also reduces signals that promote cancer cell survival, which helps delay progression of advanced HCC. The amount of benefit varies from person to person. Treatment aims to slow the cancer, not cure it.
Nexavar is a systemic treatment, so it travels through the bloodstream. It gives people whose liver cancer cannot be treated with surgery or local therapies alone an option aimed at slowing tumor growth and spread.
Nexavar works throughout the body to block cancer growth signals and reduce tumor blood supply in unresectable hepatocellular carcinoma. It helps slow the cancer but is not a cure. It should only be started and monitored under the guidance of a qualified healthcare professional.
TREATMENT PROCESS
Nexavar is supplied as an oral tablet. Take exactly as prescribed by your healthcare provider, and check with your pharmacist if you have any questions about your specific tablet strength.
The usual dose is 400 mg twice daily. Your healthcare provider determines the right dose for you and may adjust it based on how you respond and tolerate treatment.
Take Nexavar on an empty stomach, at least 1 hour before or 2 hours after a meal. Always use it exactly as your healthcare provider directs, and do not adjust your dose without medical guidance.
Nexavar is used as long-term systemic therapy in advanced liver cancer and is continued until disease progression or unacceptable toxicity occurs. Treatment duration is individualized based on response and tolerance.
Store Nexavar tablets at room temperature, away from moisture and heat.
Your healthcare provider will regularly monitor liver function, blood pressure, and treatment response. Report any side effects or unusual symptoms to your healthcare provider.
BENEFITS AND SAFETY
Nexavar (sorafenib) may support adults with unresectable hepatocellular carcinoma (HCC) by blocking multiple kinases involved in cancer cell growth and inhibiting angiogenesis, the formation of new blood vessels that feed a tumor. By reducing the blood supply tumors need and interrupting signals that promote cancer cell survival, it may help slow tumor growth and spread and delay disease progression. The extent of these benefits varies from person to person, depending on cancer stage, liver function, and how the body responds to therapy. Nexavar is not a stand-alone treatment — it works best as part of a broader, personalized care plan that combines the medication with regular monitoring, such as Liver Function Tests (LFTs), blood pressure checks, and imaging to track tumor response.
As with any medication, Nexavar may cause side effects, ranging from fatigue and diarrhea to hand-foot skin reaction, loss of appetite, and high blood pressure. Your healthcare provider will monitor your liver function and blood pressure throughout treatment and assess whether Nexavar remains a suitable option for you.
BENEFITS
Nexavar directly targets pathways involved in cancer growth. By blocking multiple kinases, it also reduces signals that promote cancer cell survival.
Nexavar helps slow tumor progression in unresectable or advanced HCC. It is continued for as long as it keeps controlling the cancer and is tolerated, and your provider reviews your response over time.
Nexavar reduces the blood supply to tumors by inhibiting angiogenesis. With less blood supply, a tumor has less of what it needs to grow and spread.
Nexavar is a tablet, so treatment does not require an injection. The usual dose is 400 mg twice daily on an empty stomach, and your provider sets the dose that is right for you.
Benefits vary from person to person. Nexavar is not a cure, and it is used with regular monitoring of liver function, blood pressure, and treatment response. Talk with your healthcare provider about whether these benefits fit your treatment goals.
These effects are often more noticeable when starting treatment and may improve with supportive care, such as skin care and activity pacing. Your healthcare provider will discuss the potential benefits and risks before treatment and provide ongoing support, including blood pressure and liver enzyme monitoring, to ensure safe use.
SUPPORTING YOUR RESULTS
Nexavar should be used together with supportive lifestyle habits that help you manage side effects and stay well through treatment. These measures remain an important part of care alongside the medication.
These habits can support how you tolerate treatment and may help you stay on therapy as prescribed.
Areas that may support treatment:
common questions
No, Nexavar is not a cure for liver cancer. It is a targeted therapy, sorafenib, used to help slow the growth and spread of unresectable hepatocellular carcinoma (HCC) by blocking cancer-cell growth signals and reducing tumor blood supply. Benefits vary from person to person, and outcomes are not guaranteed. Nexavar requires ongoing use, along with regular monitoring of liver function and blood pressure. Talk with your healthcare provider about what realistic treatment goals look like for your specific diagnosis and overall health.
Nexavar is generally intended for adults with unresectable or advanced hepatocellular carcinoma (HCC) who require systemic treatment and have adequate liver function to tolerate targeted therapy. It is typically not appropriate for people whose cancer can still be treated with surgery or local therapies, or for those with significantly impaired liver function. Your healthcare provider will review your diagnosis, cancer stage, liver function, overall health, and other medications you take before deciding whether Nexavar is a suitable option for you.
The most common side effects of Nexavar (sorafenib) include fatigue, diarrhea, hand-foot skin reaction, loss of appetite, and high blood pressure. These effects are often most noticeable when starting treatment and may ease with supportive care, such as skin care, activity pacing, and staying hydrated. Your healthcare provider will monitor you closely during treatment and can suggest ways to manage side effects. Always report new or worsening symptoms promptly so your care team can adjust your treatment plan as needed.
Nexavar is typically continued as long-term systemic therapy for as long as it keeps controlling the cancer, until disease progression or unacceptable toxicity occurs. There is no fixed length of treatment — duration is individualized based on how well you tolerate the medication and how your hepatocellular carcinoma responds over time. Your healthcare provider checks liver function, blood pressure, and imaging at regular intervals to decide whether to continue, adjust, or stop treatment. Never stop taking Nexavar without talking to your healthcare provider first.
Nexavar is an oral tablet, usually taken at a dose of 400 mg twice daily, exactly as your healthcare provider prescribes. Take it on an empty stomach, at least 1 hour before or 2 hours after a meal, to help your body absorb the medication properly. Store tablets at room temperature, away from moisture and heat. Do not change your dose or stop taking Nexavar without medical guidance, since dosing may be adjusted based on how you tolerate treatment. Ask your pharmacist if you have questions about your prescription.
While taking Nexavar, your healthcare provider regularly monitors your liver function, blood pressure, and how well the treatment is controlling your hepatocellular carcinoma. This may include blood tests, imaging, and at-home blood pressure checks. Monitoring helps your care team catch side effects early, such as high blood pressure or changes in liver enzymes, and decide whether your dose or treatment plan needs adjusting. Report any new symptoms, including skin changes on your hands or feet, fatigue, or appetite loss, to your provider promptly.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
